TITLE

Controlled Trial of Oxprenolol and Practolol in Hypertension

AUTHOR(S)
Leishman, A. W. D.; Thirkettle, J. L.; Allen, B. R.; Dixon, R. A.
PUB. DATE
November 1970
SOURCE
British Medical Journal;11/7/1970, Vol. 4 Issue 5731, p342
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64098353

 

Related Articles

  • Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy. Gallery, E.D.M.; Saunders, D.M.; Hunyor, S.N.; Gyory, A.Z. // British Medical Journal;6/16/1979, Vol. 1 Issue 6178, p1591 

    Reports the comparison of methyldopa and oxprenolol drugs for treatment of hypertension in pregnancy. Differences in the outcome of the treatment between the two drugs; Effectiveness of oxprenolol in controlling hypertension during pregnancy; Advantages of oxprenolol over methyldopa.

  • Trial of combination of guanethidine and oxprenolol in hypertension. Pearson, R.M.; Bending, M.R.; Bulpitt, C.J.; George, C.F.; Hole, D.R.; Williams, F.M.; Breckenridge, A.M. // British Medical Journal;4/17/1976, Vol. 1 Issue 6015, p933 

    Focuses on the clinical trial of guanethidine and oxprenolol combination in hypertensive patients. Evidence of additive effect on blood pressure; Effect of the combination on heart rate; Absence of correlation between the plasma oxprenolol concentration and changes in blood pressure.

  • Propranolol, oxprenolol, and sclerosing peritonitis . Marigold, J.H.; Pounder, R.E.; Pemberton, J. // British Medical Journal (Clinical Research Edition);3/20/1982, Vol. 284 Issue 6319, p870 

    Examines the effect of propranolol, oxprenolol on sclerosing peritonitis. Association of practolol with oculomucocutaneous syndrome; Assessment on radiological appearances of patients taking propranolol and oxprenolol; Implication of oxprenolol on sclerosing peritonitis.

  • oxprenolol. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p578 

    An encyclopedia entry for "oxprenolol" is presented. It refers to a beta-blocker drug used in the treatment of hypertension, angina and cardiac arrhythmias. It may also be used to relieve symptoms of anxiety and control those of hyperthyroidism.

  • Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension. Petrie, J.C.; Jeffers, T.A.; Robb, O.J.; Scott, A.K.; Webster, J. // British Medical Journal;6/28/1980, Vol. 280 Issue 6231, p1573 

    Evaluates the effect of atenolol, sustained-release oxprenolol and long-acting propranolol in hypertension. Formulation of sustained-release oxprenolol; Increase in post-exercise heart rate; Comparison of the efficacy of propranolol and oxprenolol.

  • Use of beta-blocking agents with group therapy in a smoking withdrawal clinic. Dow, Robert J.; Fee, Walter M. // Journal of the Royal Society of Medicine;Aug1984, Vol. 77 Issue 8, p648 

    A controlled trial was carried out into the relative efficacy of two beta-blocking agents (oxprenolol and metoprolol) as adjuncts to group therapy in a smoking withdrawal clinic. There was no evidence to indicate that these were of specific value in assisting smoking withdrawal.

  • Antinuclear antibodies in patients receiving non-practolol beta-blockers. Wilson, J.D.; Bullock, Jocelyn Y.; Sutherland, D.C.; Main, C.; O'Brien, K.P. // British Medical Journal;1/7/1978, Vol. 1 Issue 6104, p14 

    Antinuclear antibodies (ANA) were found in 54 (7.0%) out of 767 treated hypertensive patients compared with 59 (2.4%) out of 2470 healthy controls. Inclusion of a non-practolol beta-blocker in the treatment regimen did not significantly affect the incidence of ANA. ANA was found in significantly...

  • Renal function in patients with essential hypertension receiving nadolol. Waal-Manning, H.J.; Hobson, C.H. // British Medical Journal;8/9/1980, Vol. 281 Issue 6237, p423 

    Investigates the renal hypertension in patients with diagnosis of nadolol dose. Physiological effect of propranolol and oxprenolol on renal function; Effectiveness of antihypertensive dose of nadolol; Description of nadolol.

  • Presentation and analysis of the results of clinical trials in cardiovascular disease. Hampton, J.R. // British Medical Journal (Clinical Research Edition);4/25/1981, Vol. 282 Issue 6273, p1371 

    Evaluates the result of clinical trials in cardiovascular disease. Reduction of mortality after myocardial infarction; Comparison of oxprenolol and disopyramide with placebo treatment results; Infusion of anturane reinfarction.

  • CORRESPONDENCE. Wald, N.; Cuckle, Howard S.; Harwood, Catherine A.; Nysenbaum, A.; McFarlane, T.; Gadd, R.L.; Preston, Noel W.; Jackson, G.A.; Banks, A.W.; Hutchins, C.J.; Orme, M. L'Estrange; Serlin, M.J.; Breckenridge, A.; Sandler, Bernard; Lasagna, L.; Freedman, B.J.; Grace, A.J.; Ebbing, R.N. // British Medical Journal;8/4/1979, Vol. 2 Issue 6185, p331 

    Reports issues related to medicine. Introduction of routine antenatal screening for open neural-tube defects; Efficacy of oxprenolol in treating hypertension in pregnancy; Effectiveness of vaccines in preventing whooping-cough.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics